Spots Global Cancer Trial Database for Active Surveillance for Prostate Cancer With Indolent Features
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Active Surveillance for Prostate Cancer With Indolent Features
Official Title: Prospective Cohort Study of Active Surveillance for Prostate Cancer With Indolent Linical Features
Study ID: NCT00421265
Conditions
Interventions
Study Description
Brief Summary: In patients with prostate cancer with indolent features, disease progrssion may be very slow and in many cases will never become clinically evident during the patient's lifetime. Active surveillance is a continuous process of monitoring disease characteristcs aiming to avoid the morbidity of active therapy in patients with stabe indolent parameters, while offering early detection of disease activity in others who will need active therapy to control their disease. We hypothesize that active surveillance will permit the avoidance of therapy related morbidity in the majority of appropriate patients and will be associated with maintaining their quality of life.
Detailed Description:
Eligibility
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Assaf Harofeh Medical Center, Zerifin, , Israel
Contact Details
Name: Dan Leibovici, M.D.
Affiliation: Assaf-Harofeh Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
